Latest Form 4 insider transactions
NASDAQ
Jean Carandang, Bank Chief Financial Officer of California BanCorp \ CA, reported a transaction in 704 shares of common stock on August 2, 2026.
NASDAQ
SNEX
Stonex Group INCDhamu R. Thamodaran, a Director of StoneX Group Inc., received 142 shares of common stock on July 31, 2026.
NASDAQ
SNEX
Stonex Group INCJohn Moore Fowler, a Director of StoneX Group Inc., reported multiple transactions in common stock on July 31, 2026.
NASDAQ
SNEX
Stonex Group INCSteven A Kass, a Director of StoneX Group Inc., received 174 shares of common stock on July 31, 2026.
NASDAQ
Alberto Salamone, EVP, PPBI BUSINESS of Aehr Test Systems, reported a transaction in 204 shares of common stock on August 3, 2026.
NYSE
Hedi Tlili, Segment President of Aptargroup, Inc., sold 8,854 shares of common stock on August 3, 2026 for $135.00 per share.
NYSE
PFE
Pfizer INCForm 4: Pfizer CEO Receives Stock Grant
Albert Bourla, Chairman & CEO and a Director of Pfizer Inc, received 24 shares of common stock on July 31, 2026.
NASDAQ
Lawrence Marcus, a Director of Soundhound Ai, Inc., received 4,000 shares of common stock on July 31, 2026.
NASDAQ
Keyvan Mohajer, CEO, a Director and 10% owner of Soundhound Ai, Inc., reported multiple transactions in common stock on July 31, 2026.
NASDAQ
Majid Emami, CSO & SVP, Engineering and 10% owner of Soundhound Ai, Inc., received 400,000 shares of common stock on July 31, 2026.
NASDAQ
Michael Zagorsek, Chief Operating Officer of Soundhound Ai, Inc., reported multiple transactions in common stock on July 31, 2026.
NASDAQ
James Ming Hom, Chief Product Officer and a Director of Soundhound Ai, Inc., received 400,000 shares of common stock on July 31, 2026.
NASDAQ
Diana Sroka, a Director of Soundhound Ai, Inc., received 4,000 shares of common stock on July 31, 2026.
NASDAQ
Eric R. Ball, a Director of Soundhound Ai, Inc., received 4,000 shares of common stock on July 31, 2026.
NASDAQ
Financial For Lutherans Thrivent, a 10% owner of Gloo Holdings, Inc., sold 27,600 shares of common stock on July 30, 2026.
NASDAQ
Timothy P. Moran, Chief Business Officer of Kestra Medical Technologies, Ltd., sold 15,256 shares of common stock on July 30, 2026.
NASDAQ
STGW
Stagwell INCMark Jeffery Penn, Chief Executive Officer, a Director and 10% owner of Stagwell Inc, received 2,000,000 shares of common stock on August 1, 2026.
NASDAQ
Alfred J Ford Jr, Chief Commercial Officer of Kestra Medical Technologies, Ltd., sold 27,632 shares of common stock on July 30, 2026.
NASDAQ
Vaseem Mahboob, Chief Financial Officer of Kestra Medical Technologies, Ltd., sold 18,188 shares of common stock on July 30, 2026.
NASDAQ
Traci S Umberger, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 22,229 shares of common stock on July 30, 2026.
NASDAQ
Deep Track Biotechnology Master Fund, Ltd. and 2 others reported changes in beneficial ownership of Lb Pharmaceuticals Inc common stock on July 30, 2026.
NASDAQ
Brian Daniel Webster, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 29,822 shares of common stock on July 30, 2026.
NYSE
CSTM
Constellium SEJean-Christophe Deslarzes, a Director of Constellium Se, purchased 1,490 shares of common stock on August 3, 2026 for $27.24 per share.
NYSE
Jennifer Hsu, Chief Financial Officer of Clear Secure, Inc., received 18,208 shares of common stock on August 1, 2026.
NYSE
WHD
Cactus, INCForm 4: Cactus President Sells Shares
Joel Bender, President, a Director and 10% owner of Cactus, Inc., sold 86,700 shares of common stock on July 30, 2026 for $57.62 per share.
NYSE
WHD
Cactus, INCForm 4: Cactus CEO Sells Shares
Scott Bender, Chairman and CEO, a Director and 10% owner of Cactus, Inc., sold 86,700 shares of common stock on July 30, 2026 for $57.62 per share.
NYSE
Peter Scher, a Director of Clear Secure, Inc., reported multiple transactions in common stock on August 1, 2026.
NASDAQ
William C Boor, President & CEO and a Director of Cavco Industries Inc., reported a transaction in 128 shares of common stock on July 30, 2026.
NASDAQ
Lisa Lynn Daniels, a Director of Cavco Industries Inc., sold 30 shares of common stock on July 30, 2026 for $569.96 per share.
NASDAQ
ALKS
Alkermes PLCForm 4: Alkermes Director Sells Shares
Nancy Lynn Snyderman, a Director of Alkermes plc., sold 44,472 shares of common stock on August 3, 2026 for $50.35 per share.